(Q41213838)

28 September 2017

Pharmacokinetics and pharmacodynamics of amitriptyline in depression (English)

1 reference

https://api.crossref.org/works/10.1016/0364-7722(79)90083-3

28 June 2022

1 reference

1 reference

A. Coppen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A400982

28 June 2022

K. Ghose

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A400982

21 April 2023

A. Jørgensen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A400982

21 April 2023

language of work or name

1 reference

1 January 1979

1 reference

full work available at URL

28 September 2017

https://api.elsevier.com/content/article/PII:0364772279900833?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0364-7722(79)90083-3

https://api.elsevier.com/content/article/PII:0364772279900833?httpAccept=text/plain

21 April 2023

1 reference

https://api.crossref.org/works/10.1016/0364-7722(79)90083-3

Progress in Neuro-Psychopharmacology & Biological Psychiatry

21 April 2023

published in

1 reference

28 September 2017

3

1 reference

28 September 2017

1-3

1 reference

28 September 2017

191-199

1 reference

Relationship between plasma level and therapeutic effect of nortriptyline.

28 September 2017

1

1 reference

https://api.crossref.org/works/10.1016/0364-7722(79)90083-3

Plasma concentration of amitriptyline and clinical response

21 April 2023

3

1 reference

https://api.crossref.org/works/10.1016/0364-7722(79)90083-3

Plasma concentration of nortriptyline and clinical response in depressive illness

21 April 2023

4

1 reference

https://api.crossref.org/works/10.1016/0364-7722(79)90083-3

Amitriptyline plasma-concentration and clinical effect. A World Health Organisation Collaborative Study

21 April 2023

5

1 reference

https://api.crossref.org/works/10.1016/0364-7722(79)90083-3

Noradrenaline, depressive illness, and the action of amitriptyline

21 April 2023

7

1 reference

https://api.crossref.org/works/10.1016/0364-7722(79)90083-3

Autonomic actions and interactions of mianserin hydrochloride (Org. GB 94) and amitriptyline in patients with depressive illness

21 April 2023

8

1 reference

https://api.crossref.org/works/10.1016/0364-7722(79)90083-3

Studies of the interaction of desmethylimipramine with tyramine in man after a single oral dose, and its correlation with plasma concentration

21 April 2023

9

1 reference

https://api.crossref.org/works/10.1016/0364-7722(79)90083-3

Plasma levels and antidepressive effect of imipramine

21 April 2023

10

1 reference

https://api.crossref.org/works/10.1016/0364-7722(79)90083-3

A rating scale for depression

21 April 2023

11

1 reference

https://api.crossref.org/works/10.1016/0364-7722(79)90083-3

Plasma-nortriptyline levels in endogenous depression.

21 April 2023

13

1 reference

https://api.crossref.org/works/10.1016/0364-7722(79)90083-3

Biogenic amines and depression. Biochemical and pharmacological separation of two types of depression

21 April 2023

14

1 reference

https://api.crossref.org/works/10.1016/0364-7722(79)90083-3

CLINICAL TRIAL OF THE TREATMENT OF DEPRESSIVE ILLNESS. REPORT TO THE MEDICAL RESEARCH COUNCIL BY ITS CLINICAL PSYCHIATRY COMMITTEE

21 April 2023

15

1 reference

https://api.crossref.org/works/10.1016/0364-7722(79)90083-3

Amitriptyline plasma levels and therapeutic response

21 April 2023

16

1 reference

https://api.crossref.org/works/10.1016/0364-7722(79)90083-3

21 April 2023

Identifiers

1 reference

28 September 2017

1 reference